01 8Gowling WLG (Canada) LLP
01 42632466
02 42689663
01 2RUXOLITINIB PHOSPHATE
02 6Ruxolitinib phosphate
01 2TABLET
02 6Tablet
01 42026-12-12
02 42028-06-12
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
